GenePlanet

GenePlanet

Private
LjubljanaHealthcare & Life Scienceshttps://geneplanet.com/

Last Round

Series B

Jul 13, 2023

Total Funding Raised

$22.3M

Momentum Score

25 /100

Company Overview

GenePlanet is a biotechnology company that is a provider of innovative healthcare and lifestyle solutions based on preventive genetic testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, D2C Brands, InsurTech

Business Model

B2C

Customer Profile

Hardware Sales, Services & Consulting, Subscription SaaS, Freemium

AI Layer

Application

Keywords

genetic testingat-home DNA testpreventative healthcarepersonalized healthbiotechnologydigital health platformwhole genome sequencingWGSnon-invasive prenatal testingNIPTprecision medicinecorporate wellnessinsurtech solutionspharmacogenomicscancer genetic screeninggenomic AImicrobiome test

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GenePlanet Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

GenePlanet Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BJul 13, 2023
VC RoundJul 9, 2018

Key People

Founding team and executive leadership

Marko Bitenc

Founder And CEO

Founding Team

GenePlanet Investors

Notable investors and investment history

InvestorRounds
Designed Impact VenturesSeries B
BlackPeak CapitalSeries B
FMR d.o.o.Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors increased 33% MoM.

  • Jul 13, 2023

    $22M round led by BlackPeak Capital.

GenePlanet Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GenePlanet Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GenePlanet's valuation, stock price, and market status.

Firmographic Details

HeadquartersLjubljana
Employee Range155
Year Founded2008
Last FundingJul 13, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.